The FDA recently approved the treatment by Novo Nordisk for hemophilia A or B with inhibitors, designed to prevent or reduce ...

Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for ...

Up to half of obstructive sleep apnea patients taking Zepbound had no symptoms after one year of treatment, averaging 25 ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

The temporary spending bill that the House and Senate approved last night will keep the federal government operating through ...

A new bill in Congress would require pass-through prices in both Medicare, and Medicaid and require transparency of PBM ...

The boxed warning follows a safety warning the FDA issued in September about the risk of liver injury from the use of Veozah ...

Although the primary endpoint was not met in a phase 2 study of women who used CBD before a scan, researchers say CBD does ...

Originally approved in 2009, Stelara patents began expiring in 2023, leading to an influx of recent biosimilars.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

If approved, Molbreevi could be the first FDA-approved treatment for patients with autoimmune pulmonary alveolar proteinosis, ...

Some muscles are resistant to the loss of motor neurons seen in patients with spinal muscular atrophy, and new research has ...